SCHEMBL26109260

SCHEMBL26109260

Cn1c(Br)c(C(N)=O)c2c(N)ncnc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 1/20 0.55
▸ LRRK2 Q5S007 6/20 0.54
▸ CDK1 P06493 1/20 0.51
▸ CCNB1 P14635 1/20 0.51
▸ CCNA2 P20248 1/20 0.51
▸ CDK2 P24941 1/20 0.51
▸ CCNA1 P78396 1/20 0.51
▸ ADORA2A P29274 2/20 0.43
▸ ADORA1 P30542 2/20 0.43
▸ ADORA2B P29275 1/20 0.43
▸ HSPA8 P11142 1/20 0.41
▸ HIF1A Q16665 1/20 0.39
▸ ADK P55263 1/20 0.39
▸ RET P07949 4/20 0.39
▸ PIK3CD O00329 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ HCK P08631 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ KDR P35968 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30582626 1.00 DYRK1A (0.55) DYRK1ALRRK2CDK1CCNB1CCNA2
SCHEMBL18642946 0.78 RET (0.61) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL7701563 0.74 KDM4E (0.47) LRRK2CDK1CCNB1CCNA2CDK2
SCHEMBL7696404 0.74 ADORA2A (0.54) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL15233798 0.73 CDK1 (0.74) LRRK2CDK1CCNB1CCNA2CDK2
SCHEMBL7699720 0.72 CDK1 (0.46) LRRK2CDK1CCNB1CCNA2CDK2
SCHEMBL30582621 0.71 DYRK1A (1.00) DYRK1ALRRK2CCNA2CDK2CCNA1
SCHEMBL26110102 0.71 DYRK1A (1.00) DYRK1ALRRK2CCNA2CDK2CCNA1
SCHEMBL15233797 0.70 CCNA2 (0.74) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL18656762 0.69 DYRK1A (0.58) DYRK1ALRRK2ADORA2AADORA1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024091370-A1 5,6-FUSED BICYCLIC HETEROAROMATIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2024-05-02 — — WO disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback